Gianni, L. ., Mansutti, M. ., Anton, A. ., Calvo, L. ., Bisagni, G. ., Bermejo, B. ., … Tusquets, I. . (2018). Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-the Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2017.4612 (Original work published 2018)

Pivot, X. ., Bondarenko, I. ., Nowecki, Z. ., Dvorkin, M. ., Trishkina, E. ., Ahn, J. ., … Lim, J. . (2018). Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive.. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017740126. https://doi.org/10.1200/JCO.2017.74.0126 (Original work published 2018)